Inventor · disambiguated record
Emilio Emini
Also filed as: EMINI EMILIO A · EMINI EMILIO ANTHONY
13 granted patents·14 pending applications·215 citations·filing 1984–2023
92Inventor score
Top patents by PatentIndex Score
27 records- 0196US9492559B2Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofPFIZER·Filed 2015·Granted Nov 15, 2016·46 cites·45 claims
- 0295US11090375B2Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofPFIZER·Filed 2020·Granted Aug 17, 2021·7 cites·4 claims
- 0394US11160855B2Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofPFIZER·Filed 2016·Granted Nov 2, 2021·7 cites·48 claims
- 0491US6733993B2Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modificationsMERCK & CO INC·Filed 2001·Granted May 11, 2004·38 cites·57 claims
- 0588US11872274B2Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofPFIZER·Filed 2021·Granted Jan 16, 2024·1 cites·16 claims
- 0688US6787351B2Adenovirus carrying gag gene HIV vaccineMERCK & CO INC·Filed 2001·Granted Sep 7, 2004·23 cites·20 claims
- 0786US7598362B2Hepatitis C virus vaccineMERCK & CO INC·Filed 2002·Granted Oct 6, 2009·12 cites·50 claims
- 0870US8142794B2Hepatitis C virus vaccineEMINI EMILIO A·Filed 2009·Granted Mar 27, 2012·1 cites·27 claims
- 0970US4761470AImmunogenic synthetic peptide capable of eliciting herpes simplex virus neutralizing antibodyMERCK & CO INC·Filed 1987·Granted Aug 2, 1988·30 cites·6 claims
- 1069US5521082ANovel process for purification of hepatitis a virionsMERCK & CO INC·Filed 1992·Granted May 28, 1996·27 cites·7 claims
- 1164US5606030ACoconjugates of OMPC, HIV related peptides and anionic moietiesMERCK & CO INC·Filed 1994·Granted Feb 25, 1997·18 cites·2 claims
- 1264US2024374699A1Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses ThereofPFIZER·Filed 2023·Application pending·0 cites
- 1355US2005070017A1Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modificationsFiled 2003·Application pending·0 cites
- 1451US2008254059A1Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced TherebyBETT ANDREW J·Filed 2006·Application pending·0 cites
- 1549US2004191222A1Adenovirus serotype 34 vectors, nucleic acids and virus produced therebyFiled 2003·Application pending·0 cites
- 1649US2004101957A1Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol.nef and modificationsFiled 2001·Application pending·0 cites
- 1749US2004106194A1Methods for propagating adenovirus and virus produced therebyFiled 2003·Application pending·0 cites
- 1848US2003228329A1Adenovirus carrying gag gene HIV vaccineMERCK & CO INC·Filed 2003·Application pending·0 cites
- 1948US2004185555A1Adenovirus serotype 24 vectors, nucleic acids and virus produced therebyFiled 2003·Application pending·0 cites
- 2047US2007054395A1Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modificationsEMINI EMILIO A·Filed 2006·Application pending·0 cites
- 2146US2005106123A1Method of inducing an enhanced immune response against hivFiled 2003·Application pending·0 cites
- 2246US2006216272A1Therapeutic immunization of hiv-infected individualsEMINI EMILIO A·Filed 2004·Application pending·0 cites
- 2342US2006165664A1Method of inducing an enhanced immune response against hivEMINI EMILIO A·Filed 2003·Application pending·0 cites
- 2440US2007077257A1Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modificationsEMINI EMILIO A·Filed 2006·Application pending·0 cites
- 2538US2008063656A1Adenoviral Vector CompositionsEMINI EMILIO A·Filed 2005·Application pending·0 cites
- 2634US4596674AImmunogenic HAV peptidesMERCK & CO INC·Filed 1984·Granted Jun 24, 1986·4 cites·9 claims
- 2729US6689761B1Combination therapy for HIV infectionMERCK & CO INC·Filed 1995·Granted Feb 10, 2004·1 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →